Results 251 to 260 of about 1,616,748 (350)

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui, Marnie Bertolet, Daniel E. Forman, Michelle E. Danielson, Shanshan Yao, Oscar L. Lopez, Nancy W. Glynn, Neelesh K. Nadkarni, Akira Sekikawa, Tullia C. Bruno, Toren Finkel, Anne B. Newman   +11 more
wiley   +1 more source

Efficacy of bronchoalveolar lavage in treating mycoplasma pneumonia and bacterial pneumonia with atelectasis in children. [PDF]

Transl Pediatr
Hu M, Shen X, Li M, Ding J, Zhang Y.
europepmc   +1 more source

Age‐Specific Diagnostic Panorama Among People With Intellectual Disabilities in Comparison With the General Population: A Longitudinal Register Study (IDcare)

Journal of Intellectual Disability Research, EarlyView.
ABSTRACT Background People with intellectual disabilities (ID) are known to have a higher risk for a wide range of health conditions compared to the general population. However, there is little research comparing a more comprehensive range of diseases and conditions at different ages.
Magnus Sandberg, Jimmie Kristensson, Anna Axmon   +2 more
wiley   +1 more source

The dysregulation of innate immunity by Porphyromonas gingivalis in the etiology of Alzheimer's disease

Journal of Internal Medicine, EarlyView.
Abstract The etiology of Alzheimer's disease (AD) remains under active debate. In this perspective, we explore the hypothesis that a primarily infection‐caused chronic dysregulation and weakening of human innate immunity via the underexpression, degradation, and inactivation of innate immune proteins necessary for direct antimicrobial effects and ...
Annelise E. Barron, Jennifer S. Lin, Mark I. Ryder, Peter Bergman   +3 more
wiley   +1 more source

Fibrinogen based resuscitation mitigates lung injury in mice with bacterial pneumonia after hemorrhagic shock. [PDF]

Biochem Biophys Rep
Wu F, Cantu J, Kozar RA.
europepmc   +1 more source

CHIPing away at immunity: the role of clonal hematopoiesis of indeterminate potential in bacterial pneumonia

Elsa N. Bou Ghanem
openalex   +1 more source

Non‐steroidal anti‐inflammatory drugs versus acetaminophen and risk of venous thromboembolism: An active comparator new user cohort study

Journal of Internal Medicine, EarlyView.
Abstract Background Previous observational studies have reported an increased risk of venous thromboembolism (VTE) among non‐steroidal anti‐inflammatory drug (NSAID) users compared with non‐users. However, these studies may have been subject to bias due to unmeasured confounders related to patient conditions requiring NSAIDs.
Yuichiro Matsuo, Akira Okada, Hideo Yasunaga   +2 more
wiley   +1 more source

Guideline-concordant antibiotic prescribing for community-acquired bacterial pneumonia (CABP) due to drug-resistant pathogens in the <i>All of Us</i> database. [PDF]

J Clin Transl Sci
Gilmore CM, Vargus A, Lee GC, Schmidt S, Reveles KR, Alvarez CA, Frei CR.   +6 more
europepmc   +1 more source

Influence of nanohydroxyapatite mouthwash on the growth of Candida albicans biofilm on milled denture surfaces: An in vitro study

Journal of Prosthodontics, EarlyView.
Abstract Purpose There is a need for effective solutions for the persistent prevalence of denture stomatitis (DS) in denture‐wearing populations. This study assessed the impact of nanohydroxyapatite (nanoHAP) nanoparticles on Candida albicans biofilm formation on milled polymethylmethacrylate (PMMA) denture bases.
Cynthia U. Udeh, Bennett T. Amaechi, Parveez A. Abdul‐Azees, Amos C. Obiefuna, Chun‐Yen Lin, Nahid IftiKhar, Sunil Mankar, Temitope O. Omosebi, Tejal Gohil   +8 more
wiley   +1 more source